WA
TVGN icon

Whitebox Advisors’s Tevogen Bio Holdings TVGN Stock Holding History

Whitebox Advisors’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,712
Closed -$1.92M – 595
2022
Q4 		$1.92M Hold
3,712
– – 0.05% 183
2022
Q3 		$1.88M Hold
3,712
– – 0.05% 192
2022
Q2 		$1.86M Hold
3,712
– – 0.06% 183
2022
Q1 		$1.85M Buy
+3,712
New +$1.85M 0.04% 196

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Whitebox Advisors's TVGN Position: Q1 2023 in Review

Whitebox Advisors sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 3,712 shares — an estimated $1.92M sold.

Whitebox Advisors first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $1.92M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • Whitebox Advisors reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
  • Whitebox Advisors sold 3,712 Tevogen Bio Holdings shares in Q1 2023, an estimated $1.92M.
  • Whitebox Advisors first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 4 quarters.
  • Whitebox Advisors's Tevogen Bio Holdings position peaked at $1.92M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on Whitebox Advisors's 13F filing for Q1 2023, filed 15 May 2023.